The key goal was To judge the efficacy of the vaccine vs . placebo in reducing cocaine use. Secondary targets involved confirming vaccine immunogenicity by means of IgG anti-cocaine antibody degrees and assessing the protection and tolerability of vaccination via a twenty 7 days study and at 24 7 days https://johnz294qzf9.eedblog.com/profile